India's Ranbaxy gets Canada nod for generic drug

Reuters: "India's Ranbaxy Laboratories (RANB.BO: Quote, Profile, Research), has obtained approval to market Ran-Lisinopril in Canada, the drug maker said on Monday. A company spokesman said Ran-Lisinopril was a branded generic generic drug used to treat hypertension. "